ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at Stifel Nicolaus from $12.00 to $10.00. They now have a "buy" rating on the stock.
AbCellera Reports Full Year 2024 Business Results
Form 4 AbCellera Biologics Inc. For: Mar 11 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Mar 10 Filed by: Montalbano John S.
Form 4 AbCellera Biologics Inc. For: Mar 06 Filed by: Montalbano John S.
Form S-3ASR AbCellera Biologics Inc.
Form S-8 AbCellera Biologics Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.